Does APIXABAN Cause Treatment noncompliance? 1,749 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 1,749 reports of Treatment noncompliance have been filed in association with APIXABAN (ELIQUIS). This represents 1.1% of all adverse event reports for APIXABAN.
1,749
Reports of Treatment noncompliance with APIXABAN
1.1%
of all APIXABAN reports
38
Deaths
252
Hospitalizations
How Dangerous Is Treatment noncompliance From APIXABAN?
Of the 1,749 reports, 38 (2.2%) resulted in death, 252 (14.4%) required hospitalization, and 31 (1.8%) were considered life-threatening.
Is Treatment noncompliance Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 1,749 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Treatment noncompliance?
CLOZAPINE (2,521)
RISPERIDONE (1,986)
ARIPIPRAZOLE (1,583)
NICOTINE (1,382)
PALIPERIDONE (1,218)
ISOTRETINOIN (905)
LENALIDOMIDE (780)
OLANZAPINE (765)
TREPROSTINIL (755)
QUETIAPINE (695)
Which APIXABAN Alternatives Have Lower Treatment noncompliance Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ